|
Q2 2018
Filed on Aug 30, 2024
|
3,800
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
1,000
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
13,840
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
10,000
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
11,425
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
6,569
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
70,341
|
N/A
|
|
Dr Pepper Snapple Group Inc
|
Q3 2018
Filed on Aug 30, 2024
|
725
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
4
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
1,500
|
$3.07 - $4.08
$4.61K - $6.12K
|
|
Du Pont E I De Nemours & CO
|
Q3 2017
Filed on Aug 30, 2024
|
17,578
|
N/A
|
|
Dun & Bradstreet Corp Del Ne
|
Q3 2018
Filed on Aug 30, 2024
|
100
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
1,000
|
N/A
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
2,000
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
975
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
2,842
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
200
|
$53.03 - $59.78
$10.6K - $12K
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
3,000
|
$14.46 - $15.28
$43.4K - $45.8K
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
100
|
$41.4 - $50.46
$4.14K - $5.05K
|
|
8 Point3 Energy Partners LP
|
Q2 2018
Filed on Aug 30, 2024
|
700
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
26,421
|
N/A
|
|
Energy Transfer Prtnrs L P
|
Q2 2017
Filed on Aug 30, 2024
|
75
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
100
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
5,000
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
1,500
|
N/A
|
|
Fairmount Santrol Hldgs Inc
|
Q2 2018
Filed on Aug 30, 2024
|
6,600
|
N/A
|
|
Five Prime Therapeutics Inc
|
Q3 2018
Filed on Aug 30, 2024
|
170
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
75
|
$7.34 - $16.97
$551 - $1.27K
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
1,000
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
10,000
|
$13.03 - $15.94
$130K - $159K
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
200
|
$5.5 - $5.74
$1.1K - $1.15K
|
|
General Cable Corp Del New
|
Q2 2018
Filed on Aug 30, 2024
|
1,392
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
891
|
$3.94 - $5.25
$3.51K - $4.68K
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
5,930
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
400
|
$33.68 - $38.39
$13.5K - $15.4K
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
16,400
|
N/A
|
|
|
Q3 2017
Filed on Aug 30, 2024
|
4,500
|
$3.95 - $4.68
$17.8K - $21.1K
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
178
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
660
|
N/A
|
|
|
Q4 2017
Filed on Aug 30, 2024
|
225
|
$28.92 - $39.05
$6.51K - $8.79K
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
161
|
N/A
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
189
|
$2.95 - $4.2
$558 - $794
|
|
|
Q1 2018
Filed on Aug 30, 2024
|
200
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
1,600
|
N/A
|
|
|
Q2 2018
Filed on Aug 30, 2024
|
5,000
|
$0.62 - $0.82
$3.1K - $4.1K
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
70
|
N/A
|
|
|
Q3 2018
Filed on Aug 30, 2024
|
231
|
N/A
|
|
|
Q2 2017
Filed on Aug 30, 2024
|
800
|
N/A
|
|
Immune Pharmaceuticals Inc
|
Q2 2017
Filed on Aug 30, 2024
|
20,000
|
N/A
|
|
Platform Specialty Prods Cor
|
Q2 2018
Filed on Aug 30, 2024
|
95
|
N/A
|
|